Search hospitals > California > Woodland Hills
Kaiser Permanente-Woodland Hills
Claim this profileWoodland Hills, California 91367
Global Leader in Thyroid Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Breast cancer
120 reported clinical trials
8 medical researchers
Summary
Kaiser Permanente-Woodland Hills is a medical facility located in Woodland Hills, California. This center is recognized for care of Thyroid Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Breast cancer and other specialties. Kaiser Permanente-Woodland Hills is involved with conducting 120 clinical trials across 294 conditions. There are 8 research doctors associated with this hospital, such as Gary L. Buchschacher, Helen H. Moon, Eric C. McGary, and Ashraf R. Aziz.Area of expertise
1Thyroid Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Global LeaderStage IV
Stage II
Stage III
Top PIs
Gary L. BuchschacherKaiser Permanente-Anaheim7 years of reported clinical research
Studies Colon Cancer
Studies Stomach Cancer
14 reported clinical trials
34 drugs studied
Helen H. MoonKaiser Permanente-Riverside8 years of reported clinical research
Studies Thyroid Cancer
Studies Kidney Cancer
13 reported clinical trials
23 drugs studied
Eric C. McGaryKaiser Permanente-Anaheim10 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
11 reported clinical trials
19 drugs studied
Ashraf R. AzizKaiser Permanente-Baldwin Park6 years of reported clinical research
Studies Lymphoma
Studies T-Lymphoblastic Leukemia/Lymphoma
11 reported clinical trials
31 drugs studied
Clinical Trials running at Kaiser Permanente-Woodland Hills
Breast Cancer
Lung Cancer
Ovarian Cancer
Non-Small Cell Lung Cancer
Skin Cancer
Bladder Cancer
Stomach Cancer
Breast cancer
Prostate Cancer
Cancer
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Mobile Health
for Breast Cancer
This clinical trial compares the use of the connected customized treatment platform (CONCURxP), consisting of using a medication monitoring device called WiseBag along with text message reminders for missed or extra medication events, to enhanced usual care (EUC), where patients only use the WiseBag, to monitor medication adherence in patients with metastatic breast cancer who are taking a CKD4/6 inhibitor. To ensure CDK4/6 inhibitors achieve their full clinical benefit, patients need to take them as prescribed, following a complex treatment schedule. Forgetfulness was the most common reason reported for medication non adherence. Using the WiseBag along with CONCURxP or enhanced usual care may improve medication adherence in patients with metastatic breast cancer who are taking a CKD4/6 inhibitor.
Recruiting1 award N/A10 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Kaiser Permanente-Woodland Hills?
Kaiser Permanente-Woodland Hills is a medical facility located in Woodland Hills, California. This center is recognized for care of Thyroid Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Breast cancer and other specialties. Kaiser Permanente-Woodland Hills is involved with conducting 120 clinical trials across 294 conditions. There are 8 research doctors associated with this hospital, such as Gary L. Buchschacher, Helen H. Moon, Eric C. McGary, and Ashraf R. Aziz.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.